Product Commercialization

Expand into global markets faster with culturally relevant and compliant messaging. Choose centralized content solutions that ensure native-level localized translation, meet varied regulatory requirements on a region-by-region basis, and increase your speed to global launch.

Get in Touch
Person using iPad to analyze metrics

Comprehensive Support for Product Launches and Commercialization Plans

By partnering with TransPerfect, your team will increase preparation efficiency and shorten time to launch. Discover our complete suite of global product launch solutions.

    Digital Marketing

    Obtain strategic guidance on your omnichannel digital marketing efforts and website localization with our TPT Digital solution. Drive visibility to global marketing campaigns and create targeted messaging for your commercialization plan based on the customer journey.

    Learn More

    Translation Services

    We offer powerful technology to enable faster, more accurate translations of your product launch collateral such as app, website, brochure, and e-learning materials. TransPerfect’s GlobalLink TMS automates manual steps, drives consistency through central TMs and linguistic assets, incorporates MT workflows, and offers real-time reporting for greater visibility and control.

    Learn More

    Social Listening

    Meet with experts to review keyword requirements, search terms, and translations. TransPerfect centralizes the review of literature and streamlines the monitoring of all major social channels to understand the global sentiment around your brand.

    Learn More

    Multicultural Marketing Consulting

    Work with TransPerfect’s cultural consultants to identify your target market, how to best adapt existing marketing content, and create original content and materials that will produce the desired results.

    Learn More

    Trusted by Life Sciences Organizations Big and Small

    With TransPerfect’s support, Novartis, Pfizer, and Merck have created an average of more than $5M in savings. Partnering with TransPerfect has significantly reduced their product localization costs and made it possible for their products to launch up to 50% faster than the competition.

    Novartis
    Pfizer logo
    Merck
    Get a Free Consult ›

    Better Product Commercialization Launches by the Numbers

    30 %

    Faster Product Launch Times

    100 %

    Regulatory Compliance

    $ 5 M

    Average Saved by Novartis, Pfizer, and Merck in Product Localization

    Ready to accelerate your product launch and commercialization?

    Get in Touch ›

    News and Thought Leadership

    View industry insights from our experts. We have the experience and solutions you need to navigate life sciences complexities and bring breakthroughs from lab to launch.

    Potential Impact of the EU Biotech Act Proposal on Clinical Trial Activities

    Blog

    The European Commission’s proposed Biotech Act introduces changes that could reshape how clinical trials are approved and managed across the EU. While the broader package spans multiple areas of the health ecosystem, proposed updates to the EU Clinical Trial Regulation (EU CTR) stand out for their potential to address long-standing operational challenges including lengthy timelines, limited flexibility in submissions, and fragmented processes across member states. ...

    Potential Impact of the EU Biotech Act Proposal on Clinical Trial Activities
    Checklist

    A Checklist for eCOA Solution Deployment: Best Practices and Considerations

    Selecting and deploying a new eCOA solution involves many important factors - from determining the capabilities of the Language Service Provider (LSP) to identifying the technology used for each COA migration - and it’s impossible not to worry about missing a key detail in the ...
    Success Stories

    Fortune 500 Pharma Company Meets Critical Deadlines with TransPerfect Life Sciences’ COA Solutions

    This spotlight reviews the challenges faced by a Fortune 500 pharmaceutical company in implementing Clinical Outcome Assessments (COAs) to measure the impact of their products on patients. It discusses the need for accurate and culturally appropriate translations of COAs for ...
    White Paper

    Successful English Build & Language Migration

    Over the past decade, the global clinical trial landscape has changed drastically. A surge in technological innovation, including wearable devices, patient portals, and apps, has modernized how clinical data is collected and managed. With pen and paper becoming obsolete in the ...
    Blog

    Why 75% of Medical Device Manufacturers Are Disappointed with Their AI Results

    The Gap "The results we're seeing from AI are only as good as the data and structure we put behind it. Most manufacturers haven't done that work yet." — Marc Miller, Division President, TransPerfect Medical DeviceArtificial intelligence has arrived in medical device...
    Blog

    Metadata In, Metadata Out: Reducing RIM Submission Rework with In-System Translation

    Pharmaceutical companies spend billions and take years to bring therapies to market. Then many risk it all on a translation process managed with spreadsheets, email chains, and blind faith. Every label update, every safety amendment, every regulatory change notice must be...
    Blog

    AI Content Creation and Maintenance in Medical Information: Ending the Content Whack-a-Mole

    For many medical information (MI) teams, content maintenance can often feel like a game of whack-a-mole.Update one answer, three more pop up. Fix a regional version, and another channel drifts out of sync. Add a new piece of literature, and suddenly every approved response...